CYTK Short Interest
Cytokinetics, Incorporated
1W: -3.8%
1M: -7.0%
3M: -21.5%
YTD: -0.3%
1Y: +6.4%
3Y: +85.8%
5Y: +74.2%
$61.52
+0.79 (+1.30%)
Weekly Expected Move ±4.2%
$56
$59
$61
$64
$66
Credit Risk of going bust: lower than 65% of companies Debt: 12.9% of company value Bonds: $54.9M held by 45 funds → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.74 (down 99%), Cytokinetics, Incorporated would be worth roughly what it owes.
Total debt $1.27B against a stock market value of $8.55B.
Distance to default 6.88 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $587.2M (short-term plus half of long-term), stock volatility 42.0%; Altman Z'' -6.09. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $0.74 (down 99%), Cytokinetics, Incorporated would be worth roughly what it owes.
Total debt $1.27B against a stock market value of $8.55B.
Distance to default 6.88 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $587.2M (short-term plus half of long-term), stock volatility 42.0%; Altman Z'' -6.09. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Short Volume Summary
2026-10-2656.4%
Short Ratio
of total volume
63.5%
20-Day Avg
61.5%
50-Day Avg
▼ Falling
5-Day Trend
0.2M
Short Volume
0.3M
Total Volume
Daily Short Volume Ratio
Short Volume vs Total Volume
Exchange Breakdown
2026-10-26| Exchange | Short Volume | Total Volume | Short % |
|---|---|---|---|
| NASDAQ | 155,474 | 276,545 | 56.2% |
| NYSE | 6,583 | 10,725 | 61.4% |
| BATS | 180 | 325 | 55.4% |